These 3 Growth Stocks Are Down More Than 61% — Is Now the Time to Buy?

Tilray and SNDL are both down by over 59%, and Aurora's shares are performing even worse, losing more than 77% of their value. Considering that the market-tracking SPDR S&P 500 ETF Trust is only down by around 21.9%, it's no shock that shareholders are second-guessing their investments in these so-called growth stocks, nor is it surprising that potential buyers are hesitating to start new positions. In fact, with the exception of SNDL, their quarterly gross margins have actually gotten worse over the last three years. Read More...

Motley Fool

Why SIGA Technologies Stock Fell 31.7% in September

SIGA Technologies (NASDAQ: SIGA), a pharmaceutical company that specializes in health security countermeasures against biological, chemical, radiological, and nuclear attacks, along with vaccines and therapies to treat emerging infectious diseases, saw its shares fall 31.7% in September, according to data from S&P Global Intelligence. The company manufactures TPOXX (tecovirimat), a vaccine against monkeypox. On Sept. 19, the Food and Drug Administration (FDA) said that the vaccine, initially developed to prevent smallpox, should be restricted to only those patients with severe monkeypox disease or at high risk of severe cases of monkeypox, including people with weakened immune systems or skin conditions, such as eczema or HIV that is not virally suppressed.